| Targeting the deubiquitinase USP7 for degradation with PROTACs A Murgai, I Sosič, M Gobec, P Lemnitzer, M Proj, S Wittenburg, R Voget, ... Chemical Communications 58 (63), 8858-8861, 2022 | 32 | 2022 |
| Redox active or thiol reactive? Optimization of rapid screens to identify less evident nuisance compounds M Proj, D Knez, I Sosič, S Gobec Drug discovery today 27 (6), 1733-1742, 2022 | 18 | 2022 |
| Discovery of immunoproteasome inhibitors using large-scale covalent virtual screening A Scarpino, D Bajusz, M Proj, M Gobec, I Sosič, S Gobec, GG Ferenczy, ... Molecules 24 (14), 2590, 2019 | 16 | 2019 |
| Covalent inhibitors of bacterial peptidoglycan biosynthesis enzyme MurA with chloroacetamide warhead K Grabrijan, M Hrast, M Proj, A Dolšak, I Zdovc, T Imre, L Petri, ... European journal of medicinal chemistry 243, 114752, 2022 | 13 | 2022 |
| Andrographolide derivatives target the KEAP1/NRF2 axis and possess potent anti‐SARS‐CoV‐2 activity B Schulte, M König, BI Escher, S Wittenburg, M Proj, V Wolf, C Lemke, ... ChemMedChem 17 (5), e202100732, 2022 | 13 | 2022 |
| Discovery of selective fragment-sized immunoproteasome inhibitors L Kollár, M Gobec, B Szilágyi, M Proj, D Knez, P Ábrányi-Balogh, L Petri, ... European Journal of Medicinal Chemistry 219, 113455, 2021 | 12 | 2021 |
| Discovery of compounds with viscosity-reducing effects on biopharmaceutical formulations with monoclonal antibodies M Proj, M Zidar, B Lebar, N Strašek, G Miličić, A Žula, S Gobec Computational and structural biotechnology journal 20, 5420-5429, 2022 | 11 | 2022 |
| Leveraging ligand affinity and properties: discovery of novel benzamide-type cereblon binders for the design of PROTACs C Steinebach, A Bricelj, A Murgai, I Sosic, L Bischof, YLD Ng, C Heim, ... Journal of medicinal chemistry 66 (21), 14513-14543, 2023 | 9 | 2023 |
| Structure-activity relationships of triazole-benzodioxine inhibitors of cathepsin X UP Fonović, D Knez, M Hrast, N Zidar, M Proj, S Gobec, J Kos European Journal of Medicinal Chemistry 193, 112218, 2020 | 9 | 2020 |
| Tunable Heteroaromatic Nitriles for Selective Bioorthogonal Click Reaction with Cysteine M Proj, N Strašek, S Pajk, D Knez, I Sosič Bioconjugate chemistry 34 (7), 1271-1281, 2023 | 8 | 2023 |
| ProBiS-Dock: A hybrid multitemplate homology flexible docking algorithm enabled by protein binding site comparison J Konc, S Lesnik, B Skrlj, M Sova, M Proj, D Knez, S Gobec, D Janezic Journal of chemical information and modeling 62 (6), 1573-1584, 2022 | 8 | 2022 |
| Fragment-sized thiazoles in fragment-based drug discovery campaigns: friend or foe? M Proj, M Hrast, D Knez, K Bozovičar, K Grabrijan, A Meden, S Gobec, ... ACS medicinal chemistry letters 13 (12), 1905-1910, 2022 | 6 | 2022 |
| New inhibitors of cathepsin V impair tumor cell proliferation and elastin degradation and increase immune cell cytotoxicity A Mitrović, E Senjor, M Jukić, L Bolčina, M Prunk, M Proj, MP Nanut, ... Computational and structural biotechnology journal 20, 4667-4687, 2022 | 6 | 2022 |
| Synthesis and biochemical evaluation of warhead-decorated psoralens as (Immuno) Proteasome inhibitors ES Schiffrer, M Proj, M Gobec, L Rejc, A Šterman, J Mravljak, S Gobec, ... Molecules 26 (2), 356, 2021 | 6 | 2021 |
| Synthesis and NMR spectroscopic assignment of chlorinated benzimidazole-2-thione derivatives M Proj, I Sosič, S Gobec Tetrahedron Letters 60 (39), 151078, 2019 | 6 | 2019 |
| Encoding BRAF inhibitor functions in protein degraders DSJ Miller, SA Voell, I Sosič, M Proj, OW Rossanese, G Schnakenburg, ... RSC medicinal chemistry 13 (6), 731-736, 2022 | 5 | 2022 |
| Fragment-sized and bidentate (Immuno) proteasome inhibitors derived from cysteine and threonine targeting warheads L Kollár, M Gobec, M Proj, L Smrdel, D Knez, T Imre, Á Gömöry, L Petri, ... Cells 10 (12), 3431, 2021 | 5 | 2021 |
| The search for novel proline analogs for viscosity reduction and stabilization of highly concentrated monoclonal antibody solutions M Prašnikar, M Proj, MB Žiberna, B Lebar, B Knez, N Kržišnik, R Roškar, ... International journal of pharmaceutics 655, 124055, 2024 | 4 | 2024 |
| Optimization of triazolo [4, 5-d] pyrimidines towards human CC chemokine receptor 7 (CCR7) antagonists M Van Hoof, S Claes, M Proj, T Van Loy, D Schols, S Gobec, W Dehaen, ... European journal of medicinal chemistry 251, 115240, 2023 | 4 | 2023 |
| A set of experimentally validated decoys for the human CC chemokine receptor 7 (CCR7) obtained by virtual screening M Proj, S De Jonghe, T Van Loy, M Jukič, A Meden, L Ciber, Č Podlipnik, ... Frontiers in pharmacology 13, 855653, 2022 | 4 | 2022 |
Stanislav GobecFaculty of Pharmacy, University of Ljubljana在 ffa.uni-lj.si 的电子邮件经过验证
